What Are the 11 Material Classes in NIPS Hollow Fiber Membrane Manufacturing?

Question

Accepted Answer

Non-solvent induced phase separation (NIPS) enables scalable manufacturing of hollow fiber membranes with finely tunable selective skins and robust porous substructures. These fibers serve as compact, high–surface-area platforms across environmental filtration, hemodialysis and blood-contact devices, and gas separation processes. This blog maps the complete material toolkit used from dope preparation to post-treatment and module assembly, organized as “core function + process role + field fit,” and then compares how choices differ among the three target sectors.

What Makes NIPS Work

NIPS relies on controlled exchange between a solvent-rich polymer dope and a non-solvent (typically water). Dual diffusion triggers phase separation, fixing an asymmetric morphology: a thin selective skin (dense or finely porous) supported by a graded sponge-like or finger-like substructure. By tuning chemistry, rheology, and interfacial kinetics, engineers optimize flux, selectivity, fouling resistance, and mechanical durability.

NIPS-hollow fiber membrane spinning machine

The 11 Material Classes in the NIPS Value Chain

1. Polymer Matrix (membrane backbone)

Role: Determines mechanical strength, chemical/thermal stability, and base separation behavior; molecular structure and molecular weight strongly affect phase separation and final morphology.
Typical selections:

1）Environmental UF/MF: PSf, PES, PAN, CA, PVDF, PVC

2）Medical dialysis: medical-grade PSf, medical-grade PES, PMMA, EVOH, PLA

3）Gas separation: PI, modified PSf, CA, PMP, PDMS, PEBA

2. Solvent (dope medium)

Role: Dissolves polymer and disperses pore formers/additives; its volatility, miscibility with water, and diffusion rate set demixing speed and pore structure.
Requirements: Good polymer solvent; infinitely miscible with the non-solvent; appropriate volatility; low-tox and low-residual for medical use.
Common: DMF, DMAc, NMP, DMSO, TEP, acetone, THF

3. Non-solvent (phase-separation trigger)

Role: Essential to NIPS; composition, concentration, and temperature control demixing rate, pore type (sponge vs. finger), pore-size distribution, and skin density.
Primary bath: Deionized water (>90%).
Co-non-solvents (to slow demixing and densify skins): ethanol, glycerol, propylene glycol.

4. Pore Formers (porosity architects)

Role: Create polymer-lean domains that become pores after leaching; tune porosity, pore size, and connectivity while balancing flux and strength.
Water-soluble polymers: PVP (various Mw), PEG.
Small organic aids: glycerol, propylene glycol, ethylene glycol, diethylene glycol (DEG).
Inorganic salts: LiCl, CaCl₂, ZnCl₂ (cost-effective porosity boosters; generally avoided for dialysis/gas membranes).

5. Functional Modifiers (performance enablers)

Biocompatibility modifiers: heparin-graft polymers, MPC-type polymers, medical-grade chitosan, zwitterionics (e.g., sulfobetaine), silver nanoparticles.
Gas selectivity regulators: benzoic acid, EGDE, low-Mw plasticizers (e.g., DBP), zeolite molecular sieves, MOFs/COFs, graphene oxide.
Chemical-resistance boosters: antioxidants (e.g., 1010/168), fluorocarbon modifiers, heat stabilizers (e.g., calcium stearate), UV absorbers (e.g., UV531).
Hydrophilicity/anti-fouling aids: SPSf, HEC, modified PES, TiO₂/SiO₂/ZnO nanoparticles.
Antimicrobial agents: quaternary ammonium-modified nanomaterials, silver nanoparticles, polyphenols (e.g., gallic/tannic acid).

6. Mechanical Reinforcers

Role: Improve tensile strength, elongation at break, flexural endurance, and creep resistance; critical for high-pressure gas service, clinical handling, and long-term filtration.
Choices: nano-SiO₂, nano-TiO₂, nano-ZrO₂ (≤5%); advanced options include PES–PSf copolymers, short carbon fibers, PVDF-HFP.

7. Spinning Aids (dope/process optimizers, ≤1%)

Rheology modifiers: adjust viscosity and shear-thinning to match spinneret throughput.
Surface-tension modifiers: improve circularity, reduce pinholes (e.g., polysorbate 80, PEG fatty acid esters, Pluronic F127).
Defoamers: silicone (industrial), polyether (medical).
Stabilizers: antioxidants/thermal and light stabilizers to prevent degradation.
Antistats: reduce static, prevent fiber entanglement (e.g., SN-type, PEG esters).

8. Process Fluids

Bore fluid (inner coagulant):

1）Water (tight/small-pore inner surfaces)

2）Water/solvent mixes (water/NMP/DMAc) for delayed demixing and smoother, more open inner skins,

3）Water with glycerol/PVP for one-step inner-surface modification.

Coagulation bath (outer coagulant): deionized water; optional ethanol/glycerol to modulate demixing.

9. Post-Treatment Agents

Washing media: remove residual solvent and pore formers; deionized water is standard; dilute alcohols optional for environmental UF/MF; medical products require sterile handling.
Fixing/crosslinkers: EGDE, glutaraldehyde, isocyanates for structural stability, chemical resistance, and anti-swelling.
Humectants/anti-cracking: glycerol, PEG to preserve wet structure during drying/storage.
Extractants: ethanol, isopropanol to displace residuals (e.g., solvent/PVP).
Sterilants: ethylene oxide, gamma irradiation.

10. Compatibilizers/Nucleators

Role: Improve compatibility among multi-component formulations, control domain size, reduce microcracks/pore distortion, and promote uniform crystallization.
Options: maleic anhydride (AMAL), specialty polymer compatibilizers, inorganic nucleators (nano-CaCO₃).

11. Potting and Modular Materials

Role: Enable leak-tight, pressure-ready modules and safe storage.
Potting resins: epoxy, polyurethane, low-shrink silicone.
Housings/endcaps/seals: PC, PSU, stainless steel, PVDF; seals commonly EPDM, FKM.
· Preconditioning/storage media: for wet-stored hydrophilic and medical membranes (e.g., glycerol solutions, saline, antimicrobial preservatives).

Process Priorities by Application

· Environmental UF/MF and MBR: Favor chemical resistance, fouling control, and mechanical life under aeration/backwash cycles. Hydrophilic/anti-fouling modifiers and robust backwashable skins are key.
Medical (dialysis/blood contact): Prioritize ultra-clean dopes, narrow pore distributions, biocompatibility, sterilization stability, and extremely low extractables.
· Gas Separation: Emphasize defect-free dense skins, macrovoid suppression, plasticization resistance, and long-term selectivity under pressure and condensable exposure.

Cross-Sector Comparison

Dimension	Environmental UF/MF	Medical Dialysis/Blood-Contact	Gas Separation
Core polymers	PVDF, PES/PSf, PAN, CA, PVC	Medical-grade PSf/PES, PMMA, EVOH, PLA	PI, CA, modified PSf, PMP, PDMS, PEBA
Skin strategy	Often outer-skin, outside-in operation	Typically inner-skin for lumen control	Dense skin (inner or outer) with macrovoid suppression
Pore/form structure	Sponge-dominant for compaction resistance; controlled finger suppression	Tight, smooth, low-roughness lumen; minimal extractables	Near-surface instantaneous demixing; graded sponge backing
Key additives	Hydrophilizers, anti-foulants, oxidant-tolerant stabilizers	Biocompatible hydrophilizers, anticoagulant-like coatings, sterilant compatibility	Selectivity enhancers, crosslinkers, anti-plasticization agents
Process fluids	Water bore or water/solvent mix; DI water bath	Highly controlled bore (e.g., water or water/solvent) and sterile workflow	Precisely tuned bore/bath; temperature-controlled to avoid defects
Post-treatment	Humectants, alcohol rinses as needed	Stringent washing, sterilization (e.g., ETO or gamma)	Crosslinking/coating for stability and selectivity
QC focus	Permeance, integrity, mechanical life	Sieving curve, endotoxin/particulates, sterilization robustness	Selectivity, permeance stability, aging under pressure

Implementation Notes and Good Practices

Match polymer/solvent/non-solvent thermodynamics to the target morphology; use co-non-solvents to deliberately slow demixing for denser skins.
Select pore formers by molecular weight and miscibility to balance flux and strength; avoid certain inorganic salt pore formers where biocompatibility or gas selectivity may be compromised.
Use nano-fillers or specialty copolymers sparingly to raise strength without harming selectivity or hemocompatibility.
Enclose and condition the air gap; temperature and humidity swings shift skin density and can induce defects.
Plan solvent recovery and closed-loop handling early to reduce emissions and cost.
· Validate cleaning/sterilization compatibility with the chosen backbone and modifiers.

FAQ

1

What is the primary benefit of NIPS for hollow fibers?

It decouples a thin selective skin from a porous support, enabling high surface area, high flux, and tailored selectivity with scalable spinning.

2

Which polymers are most common by sector?

Environmental UF/MF favors PVDF, PES/PSf, PAN, and CA; medical dialysis often uses medical-grade PSf/PES or PMMA/EVOH/PLA; gas separation employs PI, CA, modified PSf, PMP, PDMS, and PEBA.

3

How do I slow demixing to form a denser skin?

Add mild co-non-solvents (e.g., ethanol or glycerol) to the coagulation bath, use water/solvent bore mixes, lower solvent–non-solvent exchange rate, and control bath temperature.

4

How are macrovoids suppressed?

Use higher bath temperatures, weaker non-solvent strength, shorter air gaps, suitable salts/additives in moderation, and stable, pulsation-free metering.

5

Which pore formers suit tight yet permeable UF structures?

PVP and PEG with tuned molecular weights, optionally blended with small polyols (glycerol, propylene glycol) to refine pore-size distribution.

6

What distinguishes medical-grade fibers?

Ultra-clean dopes, biocompatible/hydrophilic surfaces, narrow sieving profiles, validated sterilization stability, and extremely low extractables and particulates.

7

How is gas selectivity improved and stabilized?

Form defect-free dense skins via instantaneous near-surface demixing, add crosslinkers or anti-plasticizers, and incorporate selective fillers or thin coatings.

8

Which reinforcers help without harming performance?

Low-load nano-SiO₂/TiO₂/ZrO₂ or specialty copolymers; keep additions ≤ about 5% to avoid aggregation and pore distortion.

9

What post-treatments protect structure during storage?

Humectants such as glycerol or PEG to prevent pore collapse and cracking; selective crosslinking where chemical/thermal resistance is needed.

10

Are inorganic salt pore formers suitable for all sectors?

They are economical for some environmental UF/MF designs but are generally avoided for blood-contact and gas-separation membranes.

Conclusion

NIPS hollow fiber membranes succeed by aligning a disciplined material toolkit with precisely managed interfacial kinetics. From resilient UF/MF modules for water and wastewater, to biocompatible, tightly controlled dialysis fibers, to dense-skinned gas-separation elements that resist plasticization, each application leans on specific choices across the 11 material classes. By integrating polymer selection, solvent/non-solvent choreography, pore-former strategy, functional modifiers, mechanical reinforcers, and rigorous post-treatment and potting, practitioners can deliver stable, efficient, and safe membranes tailored to environmental protection, healthcare, and gas processing. As greener solvents, advanced fillers, and smarter surface chemistries mature, NIPS hollow fibers will continue to expand capability while improving sustainability and reliability.